+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?



Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?



European Respiratory Journal 33(6): 1247-1249




(PDF emailed within 0-6 h: $19.90)

Accession: 051365921

Download citation: RISBibTeXText

PMID: 19483043

DOI: 10.1183/09031936.00033809


Related references

Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension. Clinica Chimica Acta; International Journal of Clinical Chemistry 446(): 272-276, 2016

Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension. Zhonghua Er Ke Za Zhi 49(12): 886-889, 2013

Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. European Respiratory Journal 33(6): 1354-1360, 2009

Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Annals of Internal Medicine 162(2): 154-156, 2015

Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension. Pediatric Cardiology 34(4): 1006-1012, 2013

Acute pulmonary vasodilator testing is a critical step in the management of patients with pulmonary arterial hypertension. Zhonghua Jie He He Hu Xi Za Zhi 31(5): 378-380, 2008

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension. Pulmonary Circulation 5(2): 305-312, 2015

Right-heart function related to the results of acute pulmonary vasodilator testing in patients with pulmonary arterial hypertension caused by connective tissue disease. Journal of the American Society of Echocardiography 25(3): 274-279, 2012

Left and right ventricular power: outputs are the strongest hemodynamic correlates to allow identification of acute responders to vasodilator treatment in idiopathic pulmonary arterial hypertension. Archivos de Cardiologia de Mexico 81(2): 100-107, 2015

Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease?. Annals of Internal Medicine 162(2): 148-149, 2015

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respiratory Medicine 104(4): 481-496, 2010

Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing?. European Heart Journal 24(4): 297-298, 2003

Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. American Heart Journal 162(3): 562-568, 2011

What might be learned from acute pulmonary vasodilator testing in portopulmonary hypertension?. Liver Transplantation 13(11): 1498-1499, 2007

Acute vasodilator testing in primary and secondary pulmonary hypertension. Wiener Klinische Wochenschrift 113(13-14): 496-503, 16 Juli, 2001